James (Tony) Stefater

James (Tony) Stefater has a strong background in the medical field, with work experience in both the business and surgical aspects of ophthalmology. In 2016, they co-founded Pykus Therapeutics and served as the President. Their leadership skills and entrepreneurial mindset contributed to the success of the company. In 2019, they joined Ophthalmic Consultants of Boston as a Vitreoretinal Surgeon, where they continue to apply their surgical expertise in the field of ophthalmology. James (Tony) Stefater's career showcases their dedication to advancing the field of ophthalmology through business ventures and surgical practice.

James (Tony) Stefater's education history is as follows: they earned a Bachelor of Science (B.S.) degree in Biochemistry and Molecular Biology from Centre College. James (Tony) then attended the University of Cincinnati, where they obtained both a Doctor of Medicine (M.D.) degree and a Doctor of Philosophy (Ph.D.) degree in Molecular and Developmental Biology. After that, they attended Harvard Medical School and completed an internship in Internal Medicine. James (Tony) subsequently completed a residency in Ophthalmology at Harvard Medical School. Finally, they pursued further specialization by completing a fellowship in Vitreoretinal Surgery at Harvard Medical School.